The historic rise of Viagra has consistently remained a example of pharmaceutical success, but its future within the broader industry now presents questions about long-term yields . Generic versions are diminishing exclusivity , prompting anxieties that betting on companies significantly dependent to Viagra's previous position could be a dangerous